Background
DEL
Edited by: Mario Clerici, University of Milan, ItalyReviewed by: Camilla Tincati, University of Milan, Italy; Julian Olalla, Hospital Costa del Sol, SpainThe aim of this randomized clinical trial (RCT) was to compare immunological changes in virally suppressed people living with HIV (PLWH) switching from a three-drug regimen (3DR) to a two-drug regimen (2DR).